Mrs Elham Shokati
Higher Degree by Research Candidate
School of Medicine
College of Health
I am a PhD candidate at Adelaide University, studying cancer immunotherapy using single-cell genomics. My research focuses on characterising cytokine-induced killer (CIK) cells derived from colorectal cancer patients through scRNA-seq and TCR profiling, with the aim of improving immunotherapeutic strategies. I am particularly interested in translating fundamental immunology insights into clinically relevant applications.
| Year | Citation |
|---|---|
| 2023 | Shokati, E., Safari, E., & Motalebnezhad, M. (2023). Astragalus Polysaccharide Mediates Immunomodulatory Effects on Crosstalk between Human Peripheral Blood Mononuclear Cells and Ovarian Cancer Cell Line. Iranian Journal of Allergy Asthma and Immunology, 22(2), 172-182. Scopus10 WoS11 Europe PMC5 |
| 2023 | Shokati, E., & Safari, E. (2023). The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells. International Immunopharmacology, 120, 8 pages. Scopus15 WoS15 Europe PMC14 |
| 2021 | Shokati, E., Shokri, M. R., Entezami, K., Khorrami, S., Amani, M., Motallebnezhad, M., & Safari, E. (2021). Immunomodulatory effects of astragalus polysaccharide on Human peripheral blood mononuclear cells co-cultured with cervical cancer cell line. Journal of Traditional Chinese Medicine, 41(5), 684-694. Scopus12 WoS10 Europe PMC5 |
| 2021 | Amani, M., Shokati, E., Entezami, K., Khorrami, S., Jazayeri, M. H., & Safari, E. (2021). The immunomodulatory effects of low molecular weight garlic protein in crosstalk between peripheral blood mononuclear cells and colon cancer cells. Process Biochemistry, 108, 161-168. Scopus6 WoS4 |
| Year | Citation |
|---|---|
| 2026 | King, C., Iqbal, M., Shokati, E., Ying Li, C. M., Li, R., Tomita, Y., . . . Fenix, K. (2026). Comparative benchmarking of single-cell transcriptomes and immune repertoires across technologies. DOI |